激光联合雷珠单抗治疗增殖型糖尿病视网膜病变疗效观察

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (31 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of laser combined with Ranibizumab in the treatment of proliferative diabetic retinopathy.Methods A total of 110 patients with proliferative diabetic retinopathy admitted to Meizhou Hospital of Traditional Chinese Medicine from November 2018 to November 2019 were selected as the research subjects,and divided into the control group(55 cases)and the research group(55 cases)according to random number table method.The control group was given laser treatment,and the research group was given Ranibizumab treatment on the basis of the control group.The effect of treatment and the changes of retinal thickness before and after treatment were compared.Results The total effective rate of the study group was 96.4%,which was higher than that of the control group(81.8%),and the difference was statistically significant(P＜0.05).Before treatment,there was no significant difference in retinal thickness between two groups(P＞0.05).On day 30 and 90 after treatment,the retinal thickness of the two groups was lower than that before treatment,and the retinal thickness of the study group was lower than that of the control group,the differences were statistically significant(P＜0.05).Conclusion The application of laser combined with Ranibizumab in the treatment of proliferative diabetic retinopathy has significant effects,which can effectively improve patients′ visual acuity,reduce retinal thickness,stabilize retinal blood vessels,and promote the improvement of patients′ quality of life,and is worthy of clinical promotion.

Key words： Laser Ranibizumab Proliferative type Diabetic retinopathy Retinal thickness Treatment effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIU Tao
	ZENG Zhi
	LI Shu-ming

Cite this article:

LIU Tao,ZENG Zhi,LI Shu-ming. Observation on the curative effect of laser combined with Ranibizumab in the treatment of proliferative diabetic retinopathy[J]. 中国当代医药, 2021, 28(17): 137-139.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I17/137

[3]	朱博.对比激光与雷珠单抗治疗增殖型糖尿病视网膜病变的效果[J].中国保健营养，2020，30（16）：261.
[4]	管欢，邹吉新.激光联合雷珠单抗治疗增殖型糖尿病视网膜病变的疗效评价[J].中国实用医药，2019，14（6）：106-107.
[5]	徐瑞平.血清炎性因子水平在不同分期糖尿病视网膜病变患者中的变化分析[J].首都食品与医药，2020，27（15）：102.
[6]	米桂艳.激光联合雷珠单抗治疗增殖型糖尿病视网膜病变疗效分析[J].糖尿病新世界，2018，21（12）：182-183.
[7]	席桂荣，张秀艳，齐美华.激光与雷珠单抗治疗增殖型糖尿病视网膜病变[J].中国继续医学教育，2019，11（23）：135-137.
[1]	梁静.雷珠单抗联合激光治疗增殖型糖尿病视网膜病变的临床疗效分析[J].首都食品与医药，2020，27（14）：42-43.
[2]	胡红霞，侯立亭，郭洋.雷珠单抗联合全视网膜眼底激光治疗PDR 的效果[J].深圳中西医结合杂志，2020，30（10）：77-78.
[8]	万晶，孙会，清苏艺.雷珠单抗联合玻璃体切割术对PDR患者视网膜新血管形成的影响[J].检验医学与临床，2017，14（10）：1453-1455.
[9]	李景波.激光联合雷珠单抗治疗增殖型糖尿病视网膜病变的效果分析[J].航空航天医学杂志，2018，29（1）：67-68.
[10]	孙文娟，纪风涛，李永蓉.雷珠单抗对糖尿病视网膜病变患者手术前后血清VE-cadherin 和bFGF 的影响[J].河北医学，2020，26（8）：1237-1241.
[11]	陈珺，詹邶，王勇，等.玻璃体切除术前应用雷珠单抗治疗增生期糖尿病视网膜病变的疗效观察[J].临床眼科杂志，2020，28（4）：312-315.
[12]	蒋利生.玻璃体腔注射雷珠单抗联合全视网膜光凝及单纯全视网膜光凝治疗高危增殖性糖尿病视网膜病变疗效探讨[J].中国保健营养，2020，30（23）：325.
[13]	杜颖红.雷珠单抗辅助玻璃体切割术治疗增生性糖尿病视网膜病变的疗效观察[J].全科医学临床与教育，2020，18（4）：351-352，368.
[14]	马颖，徐艳丽.探讨雷珠单抗治疗糖尿病视网膜病变玻璃体出血患者的疗效[J].糖尿病天地，2020，17（1）：76-77.
[15]	林少斌，林坚，曾庆旋，等.眼底激光联合雷珠单抗治疗糖尿病视网膜病变的效果观察[J].中国实用医药，2020，15（7）：171-173.